Advanced search
Publication Cover
Blood Pressure Volume 17, 2008 - Issue 3
Submit an article Journal homepage
494
Views
9
CrossRef citations to date
0
Altmetric
Clinical Science

Progressive effects of valsartan compared with amlodipine in prevention of diabetes according to categories of diabetogenic risk in hypertensive patients: The VALUE trial

Sverre E. Kjeldsen Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI, USA; Department of Cardiology, University of Oslo, Ullevaal Hospital, Oslo, Norway
,
Gordon T. Mcinnes Division of Cardiovascular and Medical Sciences, Western Infirmary, Glasgow, Scotland
,
Giuseppe Mancia Department of Medicine, University of Milan‐Bicocca, San Gerardo Hospital, Monza‐Milan, Italy
,
Tsushung A. Hua Novartis Pharma, East Hanover, NJ, USA
,
Stevo Julius Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI, USA
,
Michael A. Weber State University of New York, Brooklyn, NY, USA
,
Antonio Coca Hypertension Unit, Hospital Clinic, Barcelona, Spain
,
Xavier Girerd Department of Endocrinology, La Pitié‐Salpêtrière Hospital, Paris, France
,
Kenneth Jamerson Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI, USA
,
Pierre Larochelle Institut de Recherches Cliniques de Montreal, Montreal, Canada
,
Thomas Macdonald Division of Medicine and Therapeutics, Ninewells Hospital and Medical School, Dundee, Scotland
,
Roland E. Schmieder Department of Nephrology, University Hospital, Erlangen, Germany
,
M. Anthony Schork Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI, USA
,
Reuven Viskoper The Israeli Forum for Prevention of Cardiovascular Diseases, Barzilai Hospital, Ashkelon, Israel
,
Jiri Widimský Department of Cardiology, Institute of Clinical and Experimental Medicine, Prague, Czech Republic
,
Alberto Zanchetti Istituto Auxologico Italiano, Ospedale Maggiore and University of Milan, Milan, Italy
&
FOR THE VALUE TRIAL INVESTIGATORS
 show all
Pages 170-177 | Received 11 Feb 2008, Accepted 17 Apr 2008, Published online: 08 Jul 2009

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Tian Shen, Jiwei Wang, Yingjun Yu & Jinming Yu. (2019) Comparison of real-world effectiveness between valsartan and non-RAS inhibitor monotherapy on the incidence of new diabetes in Chinese hypertensive patients: An electronic health recording system based study. Clinical and Experimental Hypertension 41:3, pages 244-254.
Read now
Pawan K. Porwal & Gokul S. Talele. (2017) Glycation alter serum albumin binding of valsartan and nateglinide when studied contemporarily. Journal of Liquid Chromatography & Related Technologies 40:1, pages 26-35.
Read now
Willa A. Hsueh, Laurie Orloski & Kathleen Wyne. (2010) Prediabetes: The Importance of Early Identification and Intervention. Postgraduate Medicine 122:4, pages 129-143.
Read now
Mark Greathouse. (2008) Olmesartan medoxomil-based therapy for the management of hypertension. Expert Review of Clinical Pharmacology 1:5, pages 593-604.
Read now

Articles from other publishers (5)

Nathan Artom, Fabrizio Montecucco, François Mach, Franco Dallegri & Aldo Pende. (2014) Angiotensin II receptor antagonists in acute coronary syndromes. European Journal of Clinical Investigation 44:2, pages 219-230.
Crossref
Georgia Argyrakopoulou, Costas Tsioufis, Eleni Sdraka, Dimitris Tsiachris, Konstantinos Makrilakis & Christodoulos Stefanadis. (2013) Antihypertensive treatment in diabetic patients. Review of current data. Maturitas 75:2, pages 142-147.
Crossref
Federico Soriguer, Elehazara Rubio-Martín & Gemma Rojo-Martínez. (2012) Prevención de la diabetes mellitus tipo 2. Medicina Clínica 139:14, pages 640-646.
Crossref
Deng-feng Geng, Dong-mei Jin, Wei Wu, Yun Xu & Jing-feng Wang. (2012) Angiotensin receptor blockers for prevention of new-onset type 2 diabetes: A meta-analysis of 59,862 patients. International Journal of Cardiology 155:2, pages 236-242.
Crossref
Addison A. Taylor, Helmy Siragy & Shawna Nesbitt. (2011) Angiotensin Receptor Blockers: Pharmacology, Efficacy, and Safety. The Journal of Clinical Hypertension 13:9, pages 677-686.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.